These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 11600130)
1. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase. Fujita K; Kamataki T Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130 [TBL] [Abstract][Full Text] [Related]
2. Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Kushida H; Fujita K; Suzuki A; Yamada M; Endo T; Nohmi T; Kamataki T Carcinogenesis; 2000 Jun; 21(6):1227-32. PubMed ID: 10837014 [TBL] [Abstract][Full Text] [Related]
3. Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase. Fujita K; Kamataki T Environ Mol Mutagen; 2001; 38(4):339-46. PubMed ID: 11774366 [TBL] [Abstract][Full Text] [Related]
4. Construction of Salmonella typhimurium YG7108 strains, each coexpressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase. Fujita K; Nakayama K; Yamazaki Y; Tsuruma K; Yamada M; Nohmi T; Kamataki T Environ Mol Mutagen; 2001; 38(4):329-38. PubMed ID: 11774365 [TBL] [Abstract][Full Text] [Related]
5. Role of human cytochrome P450 (CYP) in the metabolic activation of nitrosamine derivatives: application of genetically engineered Salmonella expressing human CYP. Kamataki T; Fujita K; Nakayama K; Yamazaki Y; Miyamoto M; Ariyoshi N Drug Metab Rev; 2002 Aug; 34(3):667-76. PubMed ID: 12214673 [TBL] [Abstract][Full Text] [Related]
6. Development of a Salmonella tester strain sensitive to promutagenic N-nitrosamines: expression of recombinant CYP2A6 and human NADPH-cytochrome P450 reductase in S. typhimurium YG7108. Kushida H; Fujita K; Suzuki A; Yamada M; Nohmi T; Kamataki T Mutat Res; 2000 Nov; 471(1-2):135-43. PubMed ID: 11080669 [TBL] [Abstract][Full Text] [Related]
7. Mutagenic activation of betel quid-specific N-nitrosamines catalyzed by human cytochrome P450 coexpressed with NADPH-cytochrome P450 reductase in Salmonella typhimurium YG7108. Miyazaki M; Sugawara E; Yoshimura T; Yamazaki H; Kamataki T Mutat Res; 2005 Mar; 581(1-2):165-71. PubMed ID: 15725615 [TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of CYP2A6 in relation to cancer. Kamataki T; Nunoya K; Sakai Y; Kushida H; Fujita K Mutat Res; 1999 Jul; 428(1-2):125-30. PubMed ID: 10517986 [TBL] [Abstract][Full Text] [Related]
9. Establishment of ten strains of genetically engineered Salmonella typhimurium TA1538 each co-expressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase sensitive to various promutagens. Yamazaki Y; Fujita K; Nakayama K; Suzuki A; Nakamura K; Yamazaki H; Kamataki T Mutat Res; 2004 Aug; 562(1-2):151-62. PubMed ID: 15279838 [TBL] [Abstract][Full Text] [Related]
10. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies. Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324 [TBL] [Abstract][Full Text] [Related]
11. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation. Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263 [TBL] [Abstract][Full Text] [Related]
12. Cytochrome b(5) coexpression increases the CYP2E1-dependent mutagenicity of dialkylnitrosamines in methyltransferase-deficient strains of Salmonella typhimurium. Cooper MT; Porter TD Mutat Res; 2001 Dec; 484(1-2):61-8. PubMed ID: 11733072 [TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes. Bellec G; Dréano Y; Lozach P; Ménez JF; Berthou F Carcinogenesis; 1996 Sep; 17(9):2029-34. PubMed ID: 8824531 [TBL] [Abstract][Full Text] [Related]
14. Modifications in the carcinogen-metabolizing capacity of mouse liver treated with N-nitroso compounds. Habib SL; Badawi AF; Aweny HA; Mostafa MH Oncol Rep; 1998; 5(4):965-9. PubMed ID: 9625856 [TBL] [Abstract][Full Text] [Related]
15. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Muto S; Fujita K; Yamazaki Y; Kamataki T Mutat Res; 2001 Aug; 479(1-2):197-206. PubMed ID: 11470492 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin. Takahashi E; Fujita K; Kamataki T; Arimoto-Kobayashi S; Okamoto K; Negishi T Mutat Res; 2002 Oct; 508(1-2):147-56. PubMed ID: 12379470 [TBL] [Abstract][Full Text] [Related]
17. Genotoxic activation of benzophenone and its two metabolites by human cytochrome P450s in SOS/umu assay. Takemoto K; Yamazaki H; Nakajima M; Yokoi T Mutat Res; 2002 Aug; 519(1-2):199-204. PubMed ID: 12160905 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the CYP isozyme profile induced by cyclohexanol. Espinosa-Aguirre JJ; Rubio J; López I; Nosti R; Asteinza J Mutagenesis; 1997 May; 12(3):159-62. PubMed ID: 9175641 [TBL] [Abstract][Full Text] [Related]
19. Metabolic activation of carcinogenic 1-nitropyrene by human cytochrome P450 1B1 in Salmonella typhimurium strain expressing an O-acetyltransferase in SOS/umu assay. Hatanaka N; Yamazaki H; Oda Y; Guengerich FP; Nakajima M; Yokoi T Mutat Res; 2001 Oct; 497(1-2):223-33. PubMed ID: 11525925 [TBL] [Abstract][Full Text] [Related]
20. Modulation of rat liver cytochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods [corrected]. Cancino-Badías L; Reyes RE; Nosti R; Pérez I; Dorado V; Caballero S; Soria A; Camacho-Carranza R; Escobar D; Espinosa-Aguirre JJ Mutagenesis; 2003 Jan; 18(1):95-100. PubMed ID: 12473742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]